Top

Published in:

01-09-2019 | Ameloblastoma | Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Update on Odontogenic Tumors: Proceedings of the North American Head and Neck Pathology Society

Authors: Elizabeth Ann Bilodeau, Raja R. Seethala

Published in: Head and Neck Pathology | Issue 3/2019

Abstract

Odontogenic tumors are rare entities, often derived from the epithelial remnants in the gnathic bones following odontogenesis. This brief manuscript will seek to address recent developments pertaining to odontogenic tumors as well as particularly uncommon odontogenic tumors and the difficulties in their diagnosis.

Slootweg PJ, Odell EW, Baumhoer D, Carlos R, Hunter KD, Taylor AM, et al. Data set for the reporting of malignant odontogenic tumors: explanations and recommendations of the guidelines from the international collaboration on cancer reporting (ICCR). Arch Pathol Lab Med. 2018. https://doi.org/10.5858/arpa.2018-0417-SA.CrossRefPubMed

Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER. The next-generation sequencing revolution and its impact on genomics. Cell. 2013;155(1):27–38. https://doi.org/10.1016/j.cell.2013.09.006.CrossRefPubMedPubMedCentral

Diniz MG, Gomes CC, de Sousa SF, Xavier GM, Gomez RS. Oncogenic signalling pathways in benign odontogenic cysts and tumours. Oral Oncol. 2017;72:165–73. https://doi.org/10.1016/j.oraloncology.2017.07.021.CrossRefPubMed

Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20(21):5517–26. https://doi.org/10.1158/1078-0432.CCR-14-1069.CrossRefPubMed

Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46(7):722–5. https://doi.org/10.1038/ng.2986.CrossRefPubMedPubMedCentral

Kurppa KJ, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, et al. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232(5):492–8. https://doi.org/10.1002/path.4317.CrossRefPubMedPubMedCentral

Li TJ. The odontogenic keratocyst: a cyst, or a cystic neoplasm? J Dent Res. 2011;90(2):133–42. https://doi.org/10.1177/0022034510379016.CrossRefPubMed

Gomes CC, de Sousa SF, de Menezes GH, Duarte AP, Pereira Tdos S, Moreira RG, et al. Recurrent KRAS G12V pathogenic mutation in adenomatoid odontogenic tumours. Oral Oncol. 2016;56:e3–5. https://doi.org/10.1016/j.oraloncology.2016.03.001.CrossRefPubMed

Ohata Y, Kayamori K, Yukimori A, Sumikura K, Ohsako T, Harada H, et al. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation. Pathol Int. 2018;68(5):307–12. https://doi.org/10.1111/pin.12659.CrossRefPubMed

10.

Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer Part B. 1995;31B(2):86–99.CrossRef

11.

Dassule HR, Lewis P, Bei M, Maas R, McMahon AP. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development. 2000;127(22):4775–85.PubMed

12.

Brown NA, Betz BL. Ameloblastoma: a review of recent molecular pathogenetic discoveries. Biomark Cancer. 2015;7(Suppl 2):19–24. https://doi.org/10.4137/BIC.S29329.CrossRefPubMedPubMedCentral

13.

Gultekin SE, Aziz R, Heydt C, Senguven B, Zoller J, Safi AF, et al. The landscape of genetic alterations in ameloblastomas relates to clinical features. Virchows Arch. 2018;472(5):807–14. https://doi.org/10.1007/s00428-018-2305-5.CrossRefPubMedPubMedCentral

14.

Heikinheimo K, Huhtala JM, Thiel A, Kurppa KJ, Heikinheimo H, Kovac M, et al. The mutational profile of unicystic ameloblastoma. J Dent Res. 2018:22034518798810. https://doi.org/10.1177/0022034518798810.

15.

Diniz MG, Gomes CC, Guimaraes BV, Castro WH, Lacerda JC, Cardoso SV, et al. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 2015;36(7):5649–53. https://doi.org/10.1007/s13277-015-3238-0.CrossRefPubMed

16.

Brunner P, Bihl M, Jundt G, Baumhoer D, Hoeller S. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology. Oral Oncol. 2015;51(10):e77-8. https://doi.org/10.1016/j.oraloncology.2015.07.010.CrossRefPubMed

17.

El-Naggar A, Chan J, Grandis J, Takata T, Slootweg P, editors WHO classification of head and neck tumours. 4th ed., 2017.

18.

Bilodeau E, Chiosea S, Berg A, Muller S, Purgina B, Seethala R. Molecular profiling of rare odontogenic tumors. Mod Pathol. 2018;31:473. https://doi.org/10.1038/modpathol.2018.12.CrossRef

19.

Reichart PA, Philipsen H. Calcifying ghost cell odontogenic cysts/ tumors. odontogenic tumors and allied lesions. London: Quintessence; 2004. pp. 155–78.

20.

Sekine S, Sato S, Takata T, Fukuda Y, Ishida T, Kishino M, et al. Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas. Am J Pathol. 2003;163(5):1707–12.CrossRef

21.

de Arruda JAA, Monteiro J, Abreu LG, de Oliveira Silva LV, Schuch LF, de Noronha MS, et al. Calcifying odontogenic cyst, dentinogenic ghost cell tumor, and ghost cell odontogenic carcinoma: a systematic review. J Oral Pathol Med. 2018;47(8):721–30. https://doi.org/10.1111/jop.12727.CrossRefPubMed

22.

Yukimori A, Oikawa Y, Morita KI, Nguyen CTK, Harada H, Yamaguchi S, et al. Genetic basis of calcifying cystic odontogenic tumors. PLoS ONE. 2017;12(6):e0180224. https://doi.org/10.1371/journal.pone.0180224.CrossRefPubMedPubMedCentral

23.

Bilodeau EA, Acquafondata M, Barnes EL, Seethala RR. A comparative analysis of LEF-1 in odontogenic and salivary tumors. Hum Pathol. 2015;46(2):255–9. https://doi.org/10.1016/j.humpath.2014.10.018.CrossRefPubMed

24.

Bresler SC, Padwa BL, Granter SR. Nevoid basal cell carcinoma syndrome (Gorlin Syndrome). Head Neck Pathol. 2016;10(2):119–24. https://doi.org/10.1007/s12105-016-0706-9.CrossRefPubMedPubMedCentral

25.

Qu J, Yu F, Hong Y, Guo Y, Sun L, Li X, et al. Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors. Oral Oncol. 2015;51(1):40–5. https://doi.org/10.1016/j.oraloncology.2014.09.016.CrossRefPubMed

26.

Smith MJ, Beetz C, Williams SG, Bhaskar SS, O’Sullivan J, Anderson B, et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol. 2014;32(36):4155–61. https://doi.org/10.1200/JCO.2014.58.2569.CrossRefPubMed

27.

Xu LL, Li TJ. PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome. Beijing Da Xue Xue Bao Yi Xue Ban. 2008;40(1):15–8.PubMed

28.

Waldron CA. The importance of histologic study of the various radiolucent areas of the jaws. Oral Surg Oral Med Oral Pathol. 1959;12(1):19–30.CrossRef

29.

Adorno-Farias D, Muniz V, Soares AP, Cury PR, Rabelo RG, Fernandez-Ramires R, et al. Ameloblastoma with adenoid features: a series of eight cases. Acta Histochem. 2018;120(5):468–76. https://doi.org/10.1016/j.acthis.2018.05.006.CrossRefPubMed

30.

Rai HK, Pai SM, Dayakar A, Supriya H. Adenoid ameloblastoma with dentinoid: a rare hybrid variant. J Oral Maxillofac Pathol. 2017;21(2):319. https://doi.org/10.4103/jomfp.JOMFP_53_15.CrossRefPubMedPubMedCentral

31.

Khalele BAO. Adenoid ameloblastoma with dentinoid and cellular atypia: a case report and literature review. Pathologica. 2017;109(4):379–81.PubMed

32.

Loyola AM, Cardoso SV, de Faria PR, Servato JP, Eisenberg AL, Dias FL, et al. Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(3):368–77. https://doi.org/10.1016/j.oooo.2015.05.011.CrossRefPubMed

33.

Saxena K, Jose M, Chatra LK, Sequiera J. Adenoid ameloblastoma with dentinoid. J Oral Maxillofac Pathol. 2012;16(2):272–6. https://doi.org/10.4103/0973-029X.99088.CrossRefPubMedPubMedCentral

34.

Ghasemi-Moridani S, Yazdi I. Adenoid ameloblastoma with dentinoid: a case report. Arch Iran Med. 2008;11(1):110–2. doi:08111/AIM.0021.PubMed

35.

Evans BL, Carr RF, Phillipe LJ. Adenoid ameloblastoma with dentinoid: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(5):583–8. https://doi.org/10.1016/S1079210404001866.CrossRefPubMed

36.

de Andrade Sobrinho J, de Carvalho MB, Rapoport A, Saba LM. Odontogenic adenomatoid tumor of the mandible (adenoameloblastoma). Int Surg. 1978;63(1):39–42.PubMed

37.

Tajima Y, Yokose S, Sakamoto E, Yamamoto Y, Utsumi N. Ameloblastoma arising in calcifying odontogenic cyst. Report of a case. Oral Surg Oral Med Oral Pathol. 1992;74(6):776–9.CrossRef

38.

Matsumoto Y, Mizoue K, Seto K. Atypical plexiform ameloblastoma with dentinoid: adenoid ameloblastoma with dentinoid. J Oral Pathol Med. 2001;30(4):251–4.CrossRef

39.

Ide F, Mishima K, Saito I, Kusama K. Diagnostically challenging epithelial odontogenic tumors: a selective review of 7 jawbone lesions. Head Neck Pathol. 2009;3(1):18–26. https://doi.org/10.1007/s12105-009-0107-4.CrossRefPubMedPubMedCentral

40.

Sonone A, Hande A, Chaudhary M, Sheorain A, Agni N. Adenoid ameloblastoma with dentinoid and ghost cells. A composite odontogenic tumour: a rare case report and review of the literature. Oral Surg. 2011;4:77–81.

41.

Kumar K, Shetty DC, Wadhwan V, Dhanapal R, Singh HP. Dentinoameloblastoma with ghost cells: A rare case report with emphasis on its biological behavior. Dent Res J (Isfahan). 2013;10(1):103–7. https://doi.org/10.4103/1735-3327.111809.CrossRef

42.

Bilodeau E, Seethala R. Adenoid ameloblastoma: A series of 5 tumors. Paper presented at the 72nd Annual Meeting of the American Academy Oral Maxillofacial Pathology; June 26, 2018; Vancouver.

43.

Mosqueda-Taylor A, Neville BW, Tatemoto Y, Ogawa I, Takata T. Odontogenic carcinoma with dentinoid: a new odontogenic carcinoma. Head Neck Pathol. 2014;8(4):421–31. https://doi.org/10.1007/s12105-014-0586-9.CrossRefPubMedPubMedCentral

44.

Philipsen HP, Reichart PA. Calcifying epithelial odontogenic tumour: biological profile based on 181 cases from the literature. Oral Oncol. 2000;36(1):17–26.CrossRef

45.

Kim J, Ellis GL. Dental follicular tissue: misinterpretation as odontogenic tumors. J Oral Maxillofac Surg. 1993;51(7):762–7.CrossRef

46.

Azevedo RS, Mosqueda-Taylor A, Carlos R, Cabral MG, Romanach MJ, de Almeida OP, et al. Calcifying epithelial odontogenic tumor (CEOT): a clinicopathologic and immunohistochemical study and comparison with dental follicles containing CEOT-like areas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):759–68. https://doi.org/10.1016/j.oooo.2013.08.023.CrossRefPubMed

47.

Anavi Y, Kaplan I, Citir M, Calderon S. Clear-cell variant of calcifying epithelial odontogenic tumor: clinical and radiographic characteristics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(3):332–9. https://doi.org/10.1067/moe.2003.8.CrossRefPubMed

48.

Sabir H, Kumbhare S, Redij S, Gajbhiye N. Clear Cell Variant of Calcifying epithelial odontogenic tumor: a rare clinical entity. Gulf J Oncolog. 2017;1(24):55–60.PubMed

49.

Rangel AL, da Silva AA, Ito FA, Lopes MA, de Almeida OP, Vargas PA. Clear cell variant of calcifying epithelial odontogenic tumor: is it locally aggressive? J Oral Maxillofac Surg. 2009;67(1):207–11. https://doi.org/10.1016/j.joms.2007.11.029.CrossRefPubMed

50.

Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol. 2013;37(7):1001–5. https://doi.org/10.1097/PAS.0b013e31828a6727.CrossRefPubMed

51.

Damm DD, White DK, Drummond JF, Poindexter JB, Henry BB. Combined epithelial odontogenic tumor: adenomatoid odontogenic tumor and calcifying epithelial odontogenic tumor. Oral Surg Oral Med Oral Pathol. 1983;55(5):487–96.CrossRef

52.

Eversole LR. Odontogenic fibroma, including amyloid and ossifying variants. Head Neck Pathol. 2011;5(4):335–43. https://doi.org/10.1007/s12105-011-0279-6.CrossRefPubMedPubMedCentral

53.

Ide F, Matsumoto N, Miyazaki Y, Kikuchi K, Kusama K. What is the non-calcifying langerhans cell-rich variant of calcifying epithelial odontogenic tumor? Head Neck Pathol. 2018. https://doi.org/10.1007/s12105-018-0968-5.CrossRefPubMedPubMedCentral

54.

Zhou CX, Li TJ. A clinicopathologic study on central odontogenic fibroma: with special reference to amyloid variant. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126(6):513–20. https://doi.org/10.1016/j.oooo.2018.08.019.CrossRefPubMed

55.

Santosh N, McNamara KK, Kalmar JR, Iwenofu OH. Non-calcifying langerhans cell-rich variant of calcifying epithelial odontogenic tumor: a distinct entity with predilection for anterior maxilla. Head Neck Pathol. 2018. https://doi.org/10.1007/s12105-018-0958-7.CrossRefPubMed

56.

Asano M, Takahashi T, Kusama K, Iwase T, Hori M, Yamanoi H, et al. A variant of calcifying epithelial odontogenic tumor with Langerhans cells. J Oral Pathol Med. 1990;19(9):430–4.CrossRef

57.

Wang YP, Lee JJ, Wang JT, Liu BY, Yu CH, Kuo RC, et al. Non-calcifying variant of calcifying epithelial odontogenic tumor with Langerhans cells. J Oral Pathol Med. 2007;36(7):436–9.CrossRef

58.

Junior BC, Muniz V, Vidal MTA, Gurgel CA, Leon JE, De Azevedo RA, et al. Clear cell variant of calcifying epithelial odontogenic tumor: a case report and preliminary immunohistochemical study of the SHH pathway. Appl Immunohistochem Mol Morphol. 2017;25(10):e95-e9. https://doi.org/10.1097/PAI.0000000000000467.CrossRef

59.

Peacock ZS, Cox D, Schmidt BL. Involvement of PTCH1 mutations in the calcifying epithelial odontogenic tumor. Oral Oncol. 2010;46(5):387–92. https://doi.org/10.1016/j.oraloncology.2010.02.023.CrossRefPubMed

60.

de Sousa SF, Diniz MG, Franca JA, Fontes Pereira TDS, Moreira RG, Santos JND, et al. Cancer genes mutation profiling in calcifying epithelial odontogenic tumour. J Clin Pathol. 2018;71(3):279–83. https://doi.org/10.1136/jclinpath-2017-204813.CrossRefPubMed

Title: Update on Odontogenic Tumors: Proceedings of the North American Head and Neck Pathology Society
Authors: Elizabeth Ann Bilodeau
Raja R. Seethala
Publication date: 01-09-2019
Publisher: Springer US
Keywords: Ameloblastoma
Ameloblastoma
Published in: Head and Neck Pathology / Issue 3/2019
Electronic ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-019-01013-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Update on Odontogenic Tumors: Proceedings of the North American Head and Neck Pathology Society

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases

Benign Fibro-Osseous Lesions of the Head and Neck

Current Challenges in the Staging of Oral Cancer

Challenges in Minor Salivary Gland Biopsies: A Practical Approach to Problematic Histologic Patterns

Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma

CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients